{"certainAgreement":{"otherDetails":"At the end of the trial, one or more scientific publications may be prepared collaboratively by the investigator(s) and Novo Nordisk. Novo Nordisk reserves the right to postpone publication and/or communication for up to 60 days to protect intellectual property.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"clinicaltrials@novonordisk.com","organization":"Novo Nordisk A/S","phone":"(+1) 866-867-7178","title":"Clinical Reporting Anchor and Disclosure (1452)"}}